The Metabolic Health Case for Healthcare Infrastructure Investment

A metabolic disease burden growing faster than any government can fund has turned UK healthcare into a question of private capital, and of how that capital is governed.
Coverage of health and wellness investment opportunities including digital health, GLP-1, and nutraceutical markets.

A metabolic disease burden growing faster than any government can fund has turned UK healthcare into a question of private capital, and of how that capital is governed.
For professional clients and eligible counterparties only.
Not for public distribution. This material is for information purposes and does not constitute an offer or solicitation.